INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES

INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES

Fasting during Ramadan is a major challenge for diabetics because of its various risks. A therapeutic management plan can ensure fasting while minimizing the associated risks. Our aim was to implement a pre-Ramadan management program and to define patient profiles that are more adapted to fast. Meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of advanced research (Indore) 2022-02, Vol.10 (2), p.272-279
Hauptverfasser: Ekoundzola, J.R., Dassoufi, R., Rafi, S., Mghari, G. El, Ansari, N. El
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 279
container_issue 2
container_start_page 272
container_title International journal of advanced research (Indore)
container_volume 10
creator Ekoundzola, J.R.
Dassoufi, R.
Rafi, S.
Mghari, G. El
Ansari, N. El
description Fasting during Ramadan is a major challenge for diabetics because of its various risks. A therapeutic management plan can ensure fasting while minimizing the associated risks. Our aim was to implement a pre-Ramadan management program and to define patient profiles that are more adapted to fast. Methods: 262 type 2 diabetic patients were recruited from both 2019 and 2021 Ramadan campaigns organized at the endocrinology department of the Mohammed VI University Hospital of Marrakech, excluding pregnant women and patients with chronic end-stage kidney disease. Results: Predominantly female and aged between 50 and 70 years, with a high BMI. Glycemic control was close to target for fasters. The most common comorbidities in our series were hypertension and dyslipidemia. 19.8% of our patients had an associated cardiovascular complication and 10.5% had kidney disease. After stratification, the non fasting decision concerned most of our diabetics in 2021 compared to 2019. Conclusion: A therapeutic management plan help to fit guidelines. Compared to 2017, the updated 2021 stratification guidelines are more comprehensive and have defined more non fasters patients.
doi_str_mv 10.21474/IJAR01/14204
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_21474_IJAR01_14204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_21474_IJAR01_14204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c774-7aa6c37f2b8f725024b48162297f6fba119c18fd235337fb4644f0545f652d303</originalsourceid><addsrcrecordid>eNpNkL1OwzAURi0EElXpyH5fINQ_N3HC5iZuMEqdynGEmKIkrSUQCJRMvD1Vy8D0neHTGQ4h94w-cIYS1-ZZOcrWDDnFK7LggtMoRiqv__EtWc3zO6WUCWRJJhekN9br0imvC8iV07CrC13BtnbgX_caOBRGbbTXDeyVN9r6BorWGVuCUztVKPsIeW29M5vWm9pCvQWrX6BszcljrG7uyE3oP-bj6m-XxG-1z5-iqi5NrqpolBIj2ffJKGTgQxokjynHAVOWcJ7JkIShZywbWRoOXMTidBswQQw0xjgkMT8IKpYkumjH6Wuep2Povqe3z3766RjtzoW6S6HuXEj8AifCToo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ekoundzola, J.R. ; Dassoufi, R. ; Rafi, S. ; Mghari, G. El ; Ansari, N. El</creator><creatorcontrib>Ekoundzola, J.R. ; Dassoufi, R. ; Rafi, S. ; Mghari, G. El ; Ansari, N. El ; Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition ; Mohammed VI University Hospital, Marrakesh, Morocco</creatorcontrib><description>Fasting during Ramadan is a major challenge for diabetics because of its various risks. A therapeutic management plan can ensure fasting while minimizing the associated risks. Our aim was to implement a pre-Ramadan management program and to define patient profiles that are more adapted to fast. Methods: 262 type 2 diabetic patients were recruited from both 2019 and 2021 Ramadan campaigns organized at the endocrinology department of the Mohammed VI University Hospital of Marrakech, excluding pregnant women and patients with chronic end-stage kidney disease. Results: Predominantly female and aged between 50 and 70 years, with a high BMI. Glycemic control was close to target for fasters. The most common comorbidities in our series were hypertension and dyslipidemia. 19.8% of our patients had an associated cardiovascular complication and 10.5% had kidney disease. After stratification, the non fasting decision concerned most of our diabetics in 2021 compared to 2019. Conclusion: A therapeutic management plan help to fit guidelines. Compared to 2017, the updated 2021 stratification guidelines are more comprehensive and have defined more non fasters patients.</description><identifier>ISSN: 2320-5407</identifier><identifier>EISSN: 2320-5407</identifier><identifier>DOI: 10.21474/IJAR01/14204</identifier><language>eng</language><ispartof>International journal of advanced research (Indore), 2022-02, Vol.10 (2), p.272-279</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Ekoundzola, J.R.</creatorcontrib><creatorcontrib>Dassoufi, R.</creatorcontrib><creatorcontrib>Rafi, S.</creatorcontrib><creatorcontrib>Mghari, G. El</creatorcontrib><creatorcontrib>Ansari, N. El</creatorcontrib><creatorcontrib>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition</creatorcontrib><creatorcontrib>Mohammed VI University Hospital, Marrakesh, Morocco</creatorcontrib><title>INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES</title><title>International journal of advanced research (Indore)</title><description>Fasting during Ramadan is a major challenge for diabetics because of its various risks. A therapeutic management plan can ensure fasting while minimizing the associated risks. Our aim was to implement a pre-Ramadan management program and to define patient profiles that are more adapted to fast. Methods: 262 type 2 diabetic patients were recruited from both 2019 and 2021 Ramadan campaigns organized at the endocrinology department of the Mohammed VI University Hospital of Marrakech, excluding pregnant women and patients with chronic end-stage kidney disease. Results: Predominantly female and aged between 50 and 70 years, with a high BMI. Glycemic control was close to target for fasters. The most common comorbidities in our series were hypertension and dyslipidemia. 19.8% of our patients had an associated cardiovascular complication and 10.5% had kidney disease. After stratification, the non fasting decision concerned most of our diabetics in 2021 compared to 2019. Conclusion: A therapeutic management plan help to fit guidelines. Compared to 2017, the updated 2021 stratification guidelines are more comprehensive and have defined more non fasters patients.</description><issn>2320-5407</issn><issn>2320-5407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpNkL1OwzAURi0EElXpyH5fINQ_N3HC5iZuMEqdynGEmKIkrSUQCJRMvD1Vy8D0neHTGQ4h94w-cIYS1-ZZOcrWDDnFK7LggtMoRiqv__EtWc3zO6WUCWRJJhekN9br0imvC8iV07CrC13BtnbgX_caOBRGbbTXDeyVN9r6BorWGVuCUztVKPsIeW29M5vWm9pCvQWrX6BszcljrG7uyE3oP-bj6m-XxG-1z5-iqi5NrqpolBIj2ffJKGTgQxokjynHAVOWcJ7JkIShZywbWRoOXMTidBswQQw0xjgkMT8IKpYkumjH6Wuep2Povqe3z3766RjtzoW6S6HuXEj8AifCToo</recordid><startdate>20220228</startdate><enddate>20220228</enddate><creator>Ekoundzola, J.R.</creator><creator>Dassoufi, R.</creator><creator>Rafi, S.</creator><creator>Mghari, G. El</creator><creator>Ansari, N. El</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220228</creationdate><title>INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES</title><author>Ekoundzola, J.R. ; Dassoufi, R. ; Rafi, S. ; Mghari, G. El ; Ansari, N. El</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c774-7aa6c37f2b8f725024b48162297f6fba119c18fd235337fb4644f0545f652d303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ekoundzola, J.R.</creatorcontrib><creatorcontrib>Dassoufi, R.</creatorcontrib><creatorcontrib>Rafi, S.</creatorcontrib><creatorcontrib>Mghari, G. El</creatorcontrib><creatorcontrib>Ansari, N. El</creatorcontrib><creatorcontrib>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition</creatorcontrib><creatorcontrib>Mohammed VI University Hospital, Marrakesh, Morocco</creatorcontrib><collection>CrossRef</collection><jtitle>International journal of advanced research (Indore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ekoundzola, J.R.</au><au>Dassoufi, R.</au><au>Rafi, S.</au><au>Mghari, G. El</au><au>Ansari, N. El</au><aucorp>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition</aucorp><aucorp>Mohammed VI University Hospital, Marrakesh, Morocco</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES</atitle><jtitle>International journal of advanced research (Indore)</jtitle><date>2022-02-28</date><risdate>2022</risdate><volume>10</volume><issue>2</issue><spage>272</spage><epage>279</epage><pages>272-279</pages><issn>2320-5407</issn><eissn>2320-5407</eissn><abstract>Fasting during Ramadan is a major challenge for diabetics because of its various risks. A therapeutic management plan can ensure fasting while minimizing the associated risks. Our aim was to implement a pre-Ramadan management program and to define patient profiles that are more adapted to fast. Methods: 262 type 2 diabetic patients were recruited from both 2019 and 2021 Ramadan campaigns organized at the endocrinology department of the Mohammed VI University Hospital of Marrakech, excluding pregnant women and patients with chronic end-stage kidney disease. Results: Predominantly female and aged between 50 and 70 years, with a high BMI. Glycemic control was close to target for fasters. The most common comorbidities in our series were hypertension and dyslipidemia. 19.8% of our patients had an associated cardiovascular complication and 10.5% had kidney disease. After stratification, the non fasting decision concerned most of our diabetics in 2021 compared to 2019. Conclusion: A therapeutic management plan help to fit guidelines. Compared to 2017, the updated 2021 stratification guidelines are more comprehensive and have defined more non fasters patients.</abstract><doi>10.21474/IJAR01/14204</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2320-5407
ispartof International journal of advanced research (Indore), 2022-02, Vol.10 (2), p.272-279
issn 2320-5407
2320-5407
language eng
recordid cdi_crossref_primary_10_21474_IJAR01_14204
source EZB-FREE-00999 freely available EZB journals
title INTEGRATED CARE MODEL FOR TYPE 2 DIABETES PATIENTS DURING RAMADAN: CONTRIBUTION OF NEW GUIDELINES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T15%3A14%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INTEGRATED%20CARE%20MODEL%20FOR%20TYPE%202%20DIABETES%20PATIENTS%20DURING%20RAMADAN:%20CONTRIBUTION%20OF%20NEW%20GUIDELINES&rft.jtitle=International%20journal%20of%20advanced%20research%20(Indore)&rft.au=Ekoundzola,%20J.R.&rft.aucorp=Department%20of%20Endocrinology,%20Diabetology,%20Metabolic%20Diseases%20and%20Nutrition&rft.date=2022-02-28&rft.volume=10&rft.issue=2&rft.spage=272&rft.epage=279&rft.pages=272-279&rft.issn=2320-5407&rft.eissn=2320-5407&rft_id=info:doi/10.21474/IJAR01/14204&rft_dat=%3Ccrossref%3E10_21474_IJAR01_14204%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true